Oz, Trump’s Medicare Nominee, Pledges to Divest Interests in Health Care Stocks
Posted inAppointments and Executive Changes Centers for Medicare and Medicaid Services Dietary Supplements and Herbal Remedies Ethics and Official Misconduct Health Insurance and Managed Care Medicaid Medicare Office of Government Ethics Oz, Mehmet C Presidential Transition (US) Trump, Donald J United States Politics and Government

Oz, Trump’s Medicare Nominee, Pledges to Divest Interests in Health Care Stocks

The celebrity doctor said he would divest from his interests in many drug, medical and insurance companies, worth millions of dollars.
If You’re Retired, or Not: 5 Changes That Will Affect Your Money in 2025
Posted inConsumer Financial Protection Bureau Content Type: Service Drugs (Pharmaceuticals) Elderly Health Insurance and Managed Care Income Internal Revenue Service Medicare Personal Finances Prices (Fares, Fees and Rates) Retirement Savings Social Security (US) Two Thousand Twenty Five

If You’re Retired, or Not: 5 Changes That Will Affect Your Money in 2025

This year, older workers will have ways to save more for retirement, spend less on medicine and see other ways to improve their finances.
Medicare to Negotiate Lower Prices for Weight-Loss Drugs
Posted inDrugs (Pharmaceuticals) GLP-1 RAs (Drug) Health and Human Services Department Health Insurance and Managed Care Medicare Novo Nordisk A/S Obesity Ozempic (Drug) Prices (Fares, Fees and Rates) United States Politics and Government Weight

Medicare to Negotiate Lower Prices for Weight-Loss Drugs

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.